In vivo mouse studies at 20 mg/kg subcutaneous, three injections per day for 11 days, produced reductions in body weight, white adipose mass, and adipocyte size
UH remained at No
B12 injections are medically indicated for individuals with a diagnosed B12 deficiency or conditions that impair B12 absorption, such as pernicious anemia, Crohns disease, celiac disease, or a history of gastric bypass surgery
BPC-157 peptide therapy uses BPC-157 in a highly concentrated form and is available as an injectable and as an oral supplement
TB-500, a synthetic fragment derived from thymosin beta-4, interacts with actin-associated cellular machinery that regulates cytoskeletal structure and cell migration
Food and Drug Administration (FDA)